VIJI, CHRISTEENA MARY and JOLLY, MERIN.V. and HARIKRISHNAN, S and ELSA REJI, RINKU and JESURUN R S, JACOB (2025) Unveiling the adverse effects of escitalopram: A case series analysis. World Journal of Biology Pharmacy and Health Sciences, 21 (1). pp. 626-631. ISSN 2582-5542
![[thumbnail of WJBPHS-2025-0107.pdf]](https://eprint.scholarsrepository.com/style/images/fileicons/text.png "WJBPHS-2025-0107.pdf")
Article PDF
WJBPHS-2025-0107.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike.
Abstract
Escitalopram is a Selective Serotonin Receptor Inhibitor (SSRI) prescribed for the management of anxiety, major depressive disorders, agitation, and dementia. Hyponatremia is a familiar side effect of SSRIs; however, there are only a few pieces of literature that give evidence of escitalopram-induced hyponatremia and hyponatremic encephalopathy. SSRIs are also known to cause rare neurological side effects, such as extrapyramidal symptoms like tremulousness, Parkinsonism, which often go unlisted. SSRIs may cause visual hallucinations.
| Item Type: | Article |
|---|---|
| Official URL: | https://doi.org/10.30574/wjbphs.2025.21.1.0107 |
| Uncontrolled Keywords: | Selective Serotonin Receptor Inhibitors; Hyponatremia; Hyponatremic encephalopathy; Parkinsonism; Escitalopram; Visual hallucinations; Tremulousness |
| Depositing User: | Editor WJBPHS |
| Date Deposited: | 20 Aug 2025 10:52 |
| Related URLs: | |
| URI: | https://eprint.scholarsrepository.com/id/eprint/2954 |